Maintenance of low eczema activity seen after about 80 days off tapinarof
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...
HealthDay on MSN8d
AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...
Medscape26d
Topical Psoriasis Therapies: Tapinarof, Roflumilast, and Newer Fixed Combination Topicals Show Robust Efficacy
Currently available fixed combination topicals have robust efficacy, and the recently approved cream formulations of tapinarof and roflumilast appear to have efficacy that may be higher than ...
HealthDay on MSN3d
American Academy of Dermatology, March 7 to 11
The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...
PMLive12d
Organon shares positive long-term results for Vtama cream in atopic dermatitis
Organon has shared positive results from a long-term extension (LTE) study of its Vtama (tapinarof) cream, 1% in atopic ...
Healio14d
Adults, children maintain mild AD during treatment-free period follow Vtama cream 1%
Atopic dermatitis disease activity remained mild after patients treated with Vtama cream 1% achieved nearly 80 consecutive ...
Why Organon Is A Top Pick For Income Investors
Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...
pharmaphorum9d
Dermavant raises $200m to ease launch of Otezla rival tapinarof
If approved, tapinarof's main rival will be Amgen and its oral PDE4 inhibitor Otezla (apremilast) – acquired for $13.4 billion in 2019 in side deal to Bristol-Myers Squibb's $74 billion takeover ...